Table 1:
Total | |
---|---|
| |
Number of Patients | 23 |
| |
Median age at transplant (Range) | 56.5 years (42–71) |
| |
Sex | |
Male | 15 (65.2%) |
Female | 8 (34.7%) |
| |
Light Chain | |
Kappa | 14 (60.8%) |
Lambda | 9 (39.2%) |
| |
Cytogenetic/FISH Group | |
High risk | 16 (69.5%) |
Standard risk | 7 (30.4%) |
| |
International Staging System | |
Stage 1 | 1(4.3%) |
Stage 2 | 2 (8.6%) |
Stage 3 | 14 (60.8%) |
Unknown | 6 (26%) |
| |
Disease status pre-transplant | |
CR/sCR | 3 (13%) |
nCR | 3 (13%) |
VGPR | 4 (17.3%) |
PR | 5 (21.7%) |
Stable disease/Minimal | 3 (13%) |
Progression/Relapse | 5 (21.7%) |
Abbreviations: FISH- Fluorescence in situ hybridization, CR- Complete Response, sCR- stringent Complete Response, nCR- near Complete Response, VGPR- Very Good Partial Response, PR- Partial Response